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Abstract 
Background: Malaria is endemic in countries located in tropical and sub-tropical regions. The increasing flow of 
domestic and international travellers has made malaria a relevant health problem even in non-endemic regions. 
Malaria has been described as the main diagnosis among travellers presenting febrile diseases after returning from 
tropical countries. In Brazil, malaria transmission occurs mainly in the Amazon region. Outside this area, malaria trans-
mission is of low magnitude.
Methods: This cross-sectional study aimed to describe the experience in the diagnosis of malaria in a reference 
centre located outside the Brazilian Amazon Region, emphasizing the differences in clinical and laboratory markers 
between cases of malaria and those of other febrile diseases (OFD). Medical charts from adult patients (≥18 years) 
who underwent a thick smear test (TST) for malaria, between January 2001 and December 2014, were retrospectively 
reviewed.
Results: A total of 458 cases referred to perform the TST were included. Malaria was diagnosed in 193 (42 %) epi-
sodes. The remaining 265 episodes (58 %) were grouped as OFD. The majority of malaria episodes were acquired 
in the Brazilian Amazon Region. The median time between the onset of symptoms and the TST was 7 days. Only 
53 (11.5 %) episodes were tested within the first 48 h after symptom onset. Comparing malaria with OFD, jaundice, 
nausea, vomiting, and reports of fever were more prevalent in the malaria group. Low platelet count and elevated 
bilirubin levels were also related to the diagnosis of malaria.
Conclusions: The results indicate that outside the endemic area travellers presenting febrile disease suspected of 
being malaria underwent diagnostic test after considerable delay. The reporting of fever combined with a recent 
visit to an endemic area should promptly evoke the hypothesis of malaria. In these cases, specific diagnostic tests for 
malaria should be a priority. For cases that jump this step, the presence of elevated bilirubin or thrombocytopaenia 
should also indicate a diagnosis of malaria.
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Background
Malaria is endemic in 97 countries located in tropical 
and sub-tropical regions, where an estimated 3.3 billion 
people are at risk of infection [1]. The increasing flow of 
domestic and international travellers has made malaria 
a relevant health problem even in regions that are not 
endemic for the disease. Malaria is one of the main diag-
noses among patients presenting febrile diseases after 
returning from tropical countries [2].
In the Americas, malaria occurs predominately in 
South America, where more than 70 % of cases are from 
Brazil, Venezuela and Colombia [1]. In Brazil, malaria 
transmission occurs predominantly in the Amazon Basin, 
which covers nine states: seven located in the Northern 
(Amapá, Acre, Amazonas, Pará, Rondônia, Roraima e 
Tocantins), one in the Center-West (Mato Grosso) and 
one in Northeastern (Maranhão) areas of the country 
[3, 4]. Outside this region, malaria transmission is of low 
magnitude and occurs in isolated foci. According to data 
from the Secretary of Health Surveillance of the Minis-
try of Health of Brazil, in 2014 approximately 139,000 
autochthonous malaria cases were recorded in the coun-
try. Only 54 cases with probable autochthonous trans-
mission were reported outside the Amazon region, which 
represents 0.03 % of the malaria transmission cases in the 
country for that year [5].
The case fatality rate was several times higher out-
side the Amazon region (2.68 %) than that found within 
the Amazon (0.02  %) in 2014 [5]. People living outside 
areas that are endemic for malaria are more susceptible 
to severe forms of the disease. This can be due to lack of 
specific immune response against Plasmodium, which 
depends on prolonged and repeated antigenic exposure 
[6]. Another factor to be considered is the risk of delay 
in diagnosis, as outside endemic areas physicians are less 
familiar with the management of malaria.
In this context, the present study aimed to describe 
the epidemiological, clinical and laboratory profiles of 
cases referred for malaria diagnosis, in a reference centre 
located outside the Brazilian Amazon Region. Another 
aim of the study was to identify differences in clinical and 
laboratory markers between cases of malaria and those of 
other febrile diseases (OFD).
Methods
Study design, subjects and setting
This cross-sectional study was conducted at the Univer-
sity Hospital of the Ribeirão Preto Medical School, Uni-
versity of São Paulo. It is located in the city of Ribeirão 
Preto, in the northwest region of São Paulo State, in 
southeastern Brazil (21º10′40″S, 47º48′36″W). The hos-
pital is one of fourteen reference centres of malaria 
diagnosis and treatment located in this state and covers 
90 municipalities. Patients suspected of having malaria 
are referred to the centre to perform a thick smear test 
(TST). Eventually the patients spontaneously seek the 
hospital for care. Diagnostic tests other than TST were 
not routinely performed over the period analysed. Medi-
cal charts from adult patients who underwent a TST, 
between January 2001 and December 2014, were retro-
spectively reviewed.
Adult patients (≥18 years) referred due to an acute ill-
ness, who performed the TST for diagnostic purposes, 
were included in the study. Those cases in which the TST 
was performed to monitor parasitaemia after malaria 
chemoprophylaxis or treatment were excluded. Cases of 
relapse, defined as new onset of symptoms after treatment 
in the study centre and without history of further exposure 
in risk areas, were not included. For these cases, only the 
first malaria episode was included. However, a new onset 
of symptoms in a patient who had been appropriately 
treated for malaria and was subjected to new exposure in a 
risk area was considered a new case and was included.
Standardized forms were used for data collection 
from the medical charts. Demographic data, signs and 
symptoms, time between onset of symptoms and diag-
nosis, travel history, laboratory results (complete blood 
count test, total bilirubin levels, serum creatinine, ala-
nine aminotransferase, aspartate aminotransferase, and 
TST) and chest radiograph performed up to 72  h from 
the first attendance, were registered. For clinical data, 
only records with precise information about the pres-
ence or absence of the required sign or symptom were 
considered.
Properly trained professionals performed the TST dur-
ing the first attendance, within the first hour after blood 
sample collection. Each test was independently reviewed 
by another professional.
Ethical aspects
Data were obtained from medical charts. We  have not 
obtained informed consent from participants. The study 
protocol and informed consent waiver was approved by 
the Research Ethics Committee of HCFMRP-USP (num-
ber 13388/2014).
Diagnostic definitions and malaria severity criteria
Malaria diagnosis was defined by visual detection of Plas-
modium species in the peripheral blood by TST. Patients 
were divided into two groups according to the diagnostic 
definition:
  • Malaria group: patients with a confirmed diagnosis of 
malaria.
Page 3 of 11Dotrário et al. Malar J  (2016) 15:294 
  • Other febrile diseases (OFD): patients with acute dis-
ease not diagnosed as malaria.
According to the criteria of the World Health Organiza-
tion (WHO) [7], severe malaria was defined as the pres-
ence of at least one of the following findings: impaired 
consciousness, circulatory collapse, acute renal failure 
(serum creatinine >3  mg/dL), severe anaemia (haemo-
globin <7 g/dL), jaundice associated with vital organ dys-
function, pulmonary oedema, high parasitaemia (>5  %) 
or death.
Statistical analysis
Statistic analysis was performed using SAS software (SAS 
system for Windows, version 9.2. SAS Inst, Cary, NC, 
USA). Continuous variables were expressed as median 
and interquartile range (IR). In order to compare the 
continuous variables between the two groups (malaria 
and ODF) the Mann–Whitney test was used. Qualita-
tive variables were compared using the Chi square test. 
All tests were two-tailed. A p value <.05 was considered 
significant.
Results
Characteristics of the subjects
Over the period analysed, 613 TST performances were 
registered. Of these episodes, 458 were included in the 
study, which related to 443 patients. The remaining 155 
episodes were excluded due to incomplete clinical infor-
mation and lab data (n  =  37), the subject being under 
18 years of age (n = 34), cases presenting chronic fever in 
the inpatient scenario (n = 37), the subject being asymp-
tomatic (n  =  26), prolonged fever in subjects infected 
with HIV (n = 3) and cases of malaria relapse (n = 18). 
The majority of the patients included were male (n = 380; 
83 %) with a median age of 39 years. The majority of the 
subjects were in the age group 18–50  years (n  =  345; 
75  %). Of the 458 episodes evaluated, 193 (42  %) pro-
duced a confirmed diagnosis of malaria. For the remain-
ing 265 episodes (58  %), not diagnosed as malaria, a 
syndromic or aetiological diagnosis was defined in only 
83 of them (Table 1). The median time between the onset 
of symptoms and the TST was 7 days for the sample as a 
whole. Only 53 (11.5 %) episodes were tested within the 
first 48  h after symptom onset. Specifically considering 
the 193 malaria cases, only 21 cases were tested within 
this period (10.8 %).
Clinical, epidemiological and laboratory characteristics 
of the malaria cases
Of the 193 malaria cases, the majority occurred in men, 
with a median age of 37 years. Most subjects in this group 
also belonged to the 18–50  years age group (n  =  154; 
79  %). With regard to the probable region of malaria 
infection, 73.5 % (n = 142) of the cases occurred in sub-
jects who had recently visited a Brazilian state located 
in the Amazon region. All these states represent risk 
areas for malaria, according to data from the Ministry of 
Health of Brazil. The remaining 51 cases reported recent 
travel to other countries: 18 cases had visited South 
America (Guiana, French Guiana, Venezuela, Suriname) 
and Central America (Guatemala) and, in 33 cases, the 
subjects had recently been to countries of western and 
sub-Saharan Africa (Angola, Mozambique, South Africa, 
Guinea, Equatorial Guinea, Liberia, Cameroon, Ivory 
Coast, São Tomé and Príncipe). Figure 1 shows the prob-
able geographic sites of malaria infection.
Table 1 Diagnostic condition defined in  83 non-malaria 
cases
Diagnosis Number
Visceral leishmaniasis 2
Aseptic meningitis 2
Acute diarrhea 9
Urinary tract infection 5
Dental infection 2
Acute pneumonia 8
Intra-abdominal abscess 1
Dengue 12
Common cold 5
Cholangitis 2
Spondylodiscitis 1
Leptospirosis 2
Infective endocarditis 2
Hanseniasis 1
Pharyngotonsillitis 3
Acute sinusitis 2
Cellulitis 1
Liver abscess 1
Acute toxoplasmosis 4
Histoplasmosis 3
Acute HIV infection 1
Brucellosis 1
Infectious mononucleosis 1
Hantaviruses 1
Renal lithiasis 3
Drug hypersensitivity 1
Erythema nodosum 2
Postoperative fever 1
Glomerulonephritis 1
Malignancy 2
Alcoholic hepatitis 1
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The distribution of Plasmodium species involved and 
the sites of infection are shown in Table 2. There was a 
predominance of malaria caused by Plasmodium vivax 
(n  =  132; 68.4  %) followed by Plasmodium falciparum 
(n =  45; 23.3  %). Mixed infections with P. vivax and P. 
falciparum were detected in 15 episodes (7.8  %). Only 
one case involving Plasmodium malariae was diagnosed. 
The majority of vivax malaria cases (n = 115; 87 %) were 
probably acquired in the Brazilian Amazon Region. Of 
the 45 falciparum malaria episodes, 27 were acquired in 
African countries. Severe malaria occurred in seven cases 
(4 %). One of them evolved to death. Four infections of P. 
falciparum (9 %) and three of P. vivax (2 %) were classi-
fied as severe. All seven of these cases were hospitalized. 
Three falciparum malaria cases were treated with intra-
venous artesunate and the other one with oral quinine 
sulfate plus tetracycline. All three vivax malaria episodes 
were treated with oral chloroquine plus primaquine.
A complete blood count test was available in 169 out of 
the 193 malaria episodes. Severe anaemia, defined when 
haemoglobin levels were <7 g/dL, was present in only one 
episode. However, a significant reduction in haemoglo-
bin levels (7–10  g/dL) was observed in 19 cases (11  %), 
of which 14 were due to vivax malaria. Severe thrombo-
cytopaenia (<50,000/μL) was detected in 34 cases (20 %): 
17 due to P. vivax, ten to P. falciparum and seven to 
mixed infections of P. vivax and P. falciparum. No serious 
bleeding episode was detected among these cases. In one 
malaria vivax episode, in which the platelet count was 
54,000/μL, a spontaneous sub-capsular splenic haema-
toma was diagnosed (Fig. 2). The same patient presented 
hypoalbuminaemia (serum albumin =  1.9  g/dL) associ-
ated with peripheral oedema and pleural effusion, which 
resolved after anti-malarial treatment. The majority of 
the malaria episodes were treated in an outpatient set-
ting. However, a considerable portion of malaria patients 
were hospitalized after diagnosis (n = 85; 44 %).
Clinical and epidemiological characteristics  
of non‑malaria cases
In this group, composed of 265 episodes, the majority 
of the individuals were also male (n  =  212; 80  %). The 
median age of the subjects in this group was 41 years. In 
182 cases (68.6  %), a specific diagnosis was not defined 
during the follow-up period. The majority of the cases 
were treated in an outpatient setting (n =  197; 74.3  %), 
Fig. 1 Regions of malaria infection. a Guatemala; b Venezuela; c Guyana; d Suriname; e French Guiana; f Brazil; g Guinea; h Liberia; i Côte d’Ivoire; 
j Cameroon; k Equatorial Guinea; l São Tomé and Principe; m Angola; n South Africa; o Mozambique. Cases from Brazil originated in the Amazon 
region (green area). Ribeirão Preto (study site location) is represented by the red dot
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among which 103 (52  %) did not attend the sched-
uled return visits after initial presentation. Regarding 
travel history, the majority of the patients in this group 
reported a recent visit to a Brazilian state (n  =  230; 
86.7  %), especially those located in the Amazon basin. 
Sixty-two (27  %) cases in this group had visited states 
located outside the Amazon region, of which 21 (9  %) 
reported travel to areas that are not considered at risk for 
malaria transmission.
Comparison of clinical and laboratory characteristics 
between malaria and OFD cases
The clinical characteristics of the subjects diagnosed 
with malaria and OFD are shown in Table  3. Malaria 
cases had TST performed earlier. Jaundice, nausea, 
vomiting and reports of fever in the 48 h prior to pres-
entation were more prevalent in the malaria group. The 
results of the complementary examinations are shown in 
Table 4 for both groups. Low platelet count and elevated 
bilirubin levels were the main laboratory findings related 
to malaria. A chest radiograph was more often requested 
in OFD cases than in those of malaria (24.5 vs 12.4  %; 
p  <  .001). Furthermore, malaria cases were more fre-
quently hospitalized than OFD cases (44 vs 26  %; 
p  <  .001). Considering the non-malaria cases for which 
a diagnosis was defined, dengue fever was the most fre-
quent (12/83; 14 %). Compared to the malaria (data not 
shown in the table), dengue fever was related to lower 
median levels of white blood cells [3300/μL vs 5400/μL; 
p < .001; (dengue n = 11 vs malaria n = 171)] and higher 
hemoglobin levels [14.5 vs 12.7  g/dL; p  =  .002; (den-
gue n = 11 vs malaria n = 170)]. Malaria was related to 
higher median total bilirubin levels [1.45 vs 0.43 mg/dL; 
p < .001; (dengue n = 11 vs malaria n = 146)]. Although 
the median platelet count was lower in malaria cases 
[84.5  ×  103/μL; (n  =  168)] than those of dengue fever 
[113 × 103/μL; (n = 11)], this difference was not signifi-
cant (p = .06).
Table 2 Plasmodium species according to the site of infection
Pv, Plasmodium vivax; Pf, Plasmodium falciparum; Pm, Plasmodium malariae
a Represents a severe case
b Represents a fatal case
Country State Plasmodium species (n)
Pv Pf Pv + Pf Pm Total
Brazil 115 17 9 1 142
Rondônia 39 7 4 0 50
Pará 33a 6a 1 0 40
Amazonas 11 1 1 1 14
Maranhão 10 0 2 0 12
Mato Grosso 8a 1 1 0 10
Acre 7 1 0 0 8
Roraima 3 1 0 0 4
Amapá 3 0 0 0 3
Tocantins 1 0 0 0 1
Angola 2 10a 1 0 13
Guiana 6 0 3 0 9
Mozambique 0 9b 0 0 9
French Guiana 4 1 1 0 6
South Africa 1 4a 0 0 5
Guinea 0 1 0 0 1
Guatemala 1 0 0 0 1
Equatorial Guinea 1 0 0 0 1
Venezuela 1 0 0 0 1
Ivory Coast 0 1 0 0 1
Cameroon 0 0 1 0 1
Liberia 0 1 0 0 1
São Tomé and Príncipe 0 1 0 0 1
Suriname 1 0 0 0 1
Total 132 45 15 1 193
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Discussion
This study was conducted in a university hospital located 
in Southeastern Brazil, in a state where malaria trans-
mission is infrequent and occurs in isolated areas. As 
expected, the malaria cases diagnosed reflected, for the 
most part, the endemicity of the Brazilian Amazon. None 
of the cases acquired in Brazil had a state located outside 
the Amazon region as the probable site of infection. Epi-
sodes that originated in Africa contributed to 60 % of the 
total P. falciparum infections. These cases were responsi-
ble for the higher prevalence of falciparum malaria (23 %) 
found in this study compared to that described for the 
Amazon region in 2014 (16 %) [5].
It was found that in 9 % of the non-malaria episodes 
referred to perform TST, all originating in Brazil, the 
subjects reported that they had travelled to regions 
of the country considered to be without risk for the 
transmission of malaria. This indicates that a consid-
erable number of general practitioners lack knowl-
edge regarding malaria epidemiology or have excessive 
concern with the description of sporadic autochtho-
nous cases occurring outside of the Amazon region. 
Recently, an increase in the frequency of malaria epi-
sodes was described in specific locations outside the 
Amazon region. In Goiânia City, located in Goiás State, 
central-west Brazil, between October 2014 and March 
Fig. 2 Radiologic findings of a man, 60 years of age, presenting severe vivax malaria. a Chest radiograph (PA view) showing interstitial opacities 
in both lungs compatible with pulmonary congestion. Obliteration of the costphrenic angles due to small bilateral pleural effusion can also be 
observed. b In the left lateral decubitus the pleural effusion is seen as fluid layering along the rib cage (black arrows). c Abdominal magnetic reso-
nance imaging (T1-weighted axial image) reveals spontaneous sub-capsular splenic haematoma (white arrow). d The splenic haematoma is shown 
as T1-weighted coronal MRI image (white arrow)
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2015, malaria transmission was described in a forested 
area located in the centre of the city. In the State of Rio 
de Janeiro, outside the city of Rio de Janeiro, the inci-
dence of vivax malaria has been reported to be higher 
than the annual average of six autochthonous cases. 
Between January and February 2015, 23 malaria cases 
were reported in regions covered by Atlantic Forest [8]. 
Travellers suspected of having malaria were referred 
for diagnostic testing after a considerable delay. The 
mean interval between the onset of symptoms and the 
diagnostic test was 7 days for all cases and 6 days con-
sidering only those diagnosed as malaria. Only 11.5  % 
of the cases had a TST performed in the first 48  h of 
symptoms. This differs from the practice in the Ama-
zon region, where 56.4 % of malaria cases, in 2011, were 
diagnosed and treated within the first 48 h of symptom 
onset [9]. The delay observed in this study indicates a 
low index of suspicion for malaria by physicians work-
ing outside the endemic areas. In reference centres 
located in the Amazon region, the TST is a priority test 
for patients presenting acute febrile disease.
Despite this delay in completing the diagnostic test, 
only seven severe malaria episodes (4 %) were found and 
there was only one death during the 14-year period eval-
uated in the study. In a university hospital with charac-
teristics similar to that of the study centre, located in the 
city of Campinas, also in São Paulo State, there were no 
cases of death among 263 malaria cases treated between 
1998 and 2011. In that study, the authors also found a 
mean interval between the onset of symptoms and the 
diagnosis of 6  days for infections caused by P. vivax. 
However, this interval was slightly lower (4 days) for fal-
ciparum malaria episodes [10].
The low percentage of severe malaria found in the pre-
sent study may be partly explained by the prevalence of 
non-falciparum malaria episodes. This is a reflection of 
the distribution of Plasmodium species in Brazil. Accord-
ing to the latest bulletin of the Ministry of Health, P. 
vivax was responsible for 84  % of the reported malaria 
episodes, while P. falciparum occurred in only 16  % of 
them (5). In the USA, where almost 60 % of malaria cases 
among travellers in 2012, were caused by P. falciparum, 
Table 3 Demographic and clinical characteristics of malaria and other febrile diseases
p value <.05 was considered statistically significant
Mann–Whitney test was used to compare continuous variables between the groups
Chi square test was used to compare categorical variables between the groups
OFD other febrile diseases, IQR interquartile range, TST thick smear test
a Proportion of positive results of the total cases where the variable was accurately recorded
b Report of fever (symptom)
Variable Malaria OFD p value
Age (years) [median (IQR)] 37 (29.0–48.0) 41 (31.0–52.0) .03
Males [n (%)] 167 (86.5) 212 (80) NS
Interval from presentation to TST (days) [median (IQR)] 6 (3.0–10.0) 7 (4.0–15.0) .04
Chills [proportiona (%)] 118/124 (95.2) 115/125 (92.0) NS
Myalgia [proportiona (%)] 113/120 (94.2) 148/166 (89.2) NS
Jaundice [proportiona (%)] 41/175 (23.4) 27/222 (12.2) <.01
Cough [proportiona (%)] 27/100 (27.0) 63/154 (40.9) .02
Dyspnea [proportiona (%)] 15/105 (14.3) 15/109 (13.8) NS
Nasal discharge [proportiona (%)] 3/36 (8.3) 16/55 (29.1) .02
Nasal obstruction [proportiona (%)] 5/37 (13.5) 12/43 (27.9) NS
Chest pain [proportiona (%)] 2/40 (5) 15/65 (23.1) .01
Cervical lymphadenopathy [proportiona (%)] 4/57 (7) 24/88 (27.3) <.01
Nausea [proportiona (%)] 58/112 (51.8) 42/114 (36.8) .02
Vomiting [proportiona (%)] 60/136 (44.1) 31/129 (24.0) <.01
Diarrhea [proportiona (%)] 22/136 (16.2) 52/157 (33.1) <.01
Sore throat [proportiona (%)] 4/43 (9.3) 15/53 (28.3) .02
Abdominal pain [proportiona (%)] 43/72 (59.7) 48/82 (58.5) NS
Headache [proportiona (%)] 120/138 (87.0) 137/166 (82.5) NS
Retro-orbital pain [proportiona (%)] 25/40 (62.5) 30/46 (65.2) NS
Hepatomegaly [proportiona (%)] 35/184 (19.0) 38/327 (16.0) NS
Splenomegaly [proportiona (%)] 20/183 (10.9) 18/237 (7.6) NS
Feverb [proportiona (%)] 193/193 (100 %) 242/258 (93.8) <.01
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14 % of the episodes were classified as severe. The major-
ity of the severe cases (75 %) were due to P. falciparum 
[11]. In this same study, considering only individuals 
aged ≥18 years, the percentage of severe cases (11 %) was 
still greater than that verified in the present study. Data 
related to imported cases of malaria in the UK, between 
1987 and 2006, indicate that the case fatality rate among 
falciparum malaria episodes (0.73 %) was 15 times greater 
than those of non-falciparum malaria (0.05 %) [12]. The 
non-inclusion of children, a risk group for severe malaria, 
may also have contributed to the low percentage of 
severe cases found in the present study. Mascarello et al. 
[13], in a study conducted on imported malaria infec-
tions in Italy, found 4.5 % severe malaria episodes among 
adults, compared to 18.6 % among subjects younger than 
15 years.
In spite of the delay in the referral to perform a TST, 
it can be assumed that, for the majority of the subjects 
tested, diagnosis and treatment was completed within 
a period sufficient to prevent the onset of complica-
tions. This is not only supported by the low percentage 
of severe forms, but also by the evaluation of the labora-
tory results of the malaria cases at the moment of diag-
nosis. The mean haemoglobin and serum creatinine 
values were normal, with bilirubin levels and platelets 
count presenting mild abnormalities. However, a number 
of patients presented relevant laboratory abnormalities 
at the moment of evaluation. Moderate anaemia (hae-
moglobin  =  7–10  g/dL) and severe thrombocytopaenia 
(<50,000/μL) were detected in 11.3 and 20  %, respec-
tively. Although these abnormalities are not markers of 
severe malaria, they can increase severity in the presence 
of co-morbidities [14].
The low mortality and severity rates observed in this 
study may be underestimated due to selection bias. Cases 
in which malaria was not suspected may not have been 
referred to the study centre. The fatality rate of cases 
reported outside the Brazilian Amazon Region is several 
times higher than that described within the Amazon. 
Between 2000 and 2011, this indicator ranged from 0.04 
to 0.02  % and from 0.6 to 1.8  % within and outside the 
Amazon region, respectively [9]. A low index of diagnos-
tic suspicion for malaria by physicians working outside 
the endemic areas is the main reason for this scenario. 
This assumption is supported by findings observed in 
other regions of Brazil [15] and other countries [12, 16], 
which relate a delay in diagnosis to malaria mortality in 
non-endemic areas. Considering that malaria preva-
lence has decreased globally over the past years [1], this 
could be particularly concerning. As in some areas where 
malaria has become progressively less common, clini-
cians will have less experience in making diagnosis.
Three severe vivax malaria episodes were detected. 
Furthermore, infections due to P. vivax were responsi-
ble for 73.6 % of the moderate anaemia cases and 50 % of 
severe thrombocytopaenia. One of these cases presented 
severe hypoalbuminaemia associated with peripheral 
oedema, pleural effusion and pulmonary congestion.
Comparing malaria with OFD, the detection of jaundice 
and the report of nausea, vomiting and fever were more 
prevalent in the patients with malaria. Fever has been 
reported in at least 90 % of subjects diagnosed with malaria 
Table 4 Laboratory findings of malaria and other febrile diseases (OFD)
p value <.05 was considered statistically significant
Mann–Whitney test was used to compare variables between the groups
OFD other febrile diseases IQR interquartile range, WBC white blood cells, NS not significant
a Performed in 169 malaria and 210 OFD cases
b Performed in 163 malaria and 184 OFD cases
c Performed in 66 malaria and 87 OFD cases
d Performed in 145 malaria and 157 OFD cases
e Performed in 157 malaria and 172 OFD cases
Variable  
[median (IQR)]
Malaria OFD p value
Hemoglobin (g/dL)a 12.7 (11.5–14.2) 13.9 (12.8–15.0) <.01
Hematocrit (%)a 38.8 (34.0–42.0) 42.0 (38.2–45.0) <.01
WBC (μL)a 5400.0 (4300.0–6900.0) 6650.0 (4700.0–8900.0) <.01
Platelet × 103 (μL)a 84.5 (55.5–131.0) 204.0 (148.0–269.0) <.01
AST (U/L)b 31.5 (23.0–48.0) 32.0 (22.8–51.0) NS
ALT (U/L)c 43.6 (28.0–60.0) 49.5 (30.0–89.0) NS
Total Bilirubin (mg/dL)d 1.45 (0.96–2.27) 0.58 (0.42–1.03) <.01
Serum creatinine (mg/dL)e 1.0 (0.9–1.2) 1.0 (0.9–1.2) NS
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and is the main reason for seeking care among travel-
lers with malaria, according to different studies [2, 17–19]. 
Although fever is an important clue for the diagnosis of 
malaria, some considerations need to be made. Despite 
fever being frequently reported, temperature ≥38.0  °C is 
not detected in a considerable proportion of patients at the 
moment of diagnosis [18]. Furthermore, as fever is the main 
reason why travellers seek medical evaluation, the high prev-
alence of this symptom in several studies can be associated 
with reference bias. Absence of fever can be observed more 
frequently in subjects undergoing chemoprophylaxis [20] 
and in semi-immune individuals, which is seen more among 
inhabitants of endemic areas [21, 22]. Nausea and vomiting 
have been reported in 13–45 % of imported malaria cases 
[16, 18, 23, 24]. Nonetheless, these symptoms are too unspe-
cific to be used as clinical predictors of malaria [25]. Thus, 
they must be recognized as possible clinical manifestations 
of malaria and should not devalue this diagnosis in favour of 
diseases in which the symptoms are predominantly gastro-
intestinal, such as acute gastroenteritis, viral hepatitis and 
typhoid fever, which are also commonly diagnosed among 
travellers returning from the tropics [2, 26].
In relation to clinical aspects, a higher prevalence of 
upper airway symptoms, such as cough, nasal discharge 
and sore throat, was found among the non-malaria cases. 
Cervical adenopathy and diarrhoea were also more prev-
alent in this group. These signs and symptoms suggest 
that viral or bacterial diseases of the upper airways and 
gastrointestinal tract probably occurred in a considerable 
number of the non-malaria cases. In this group, upper 
airway and gastrointestinal infections, taken together, 
occurred in a third of the cases in which a diagnosis was 
defined. This finding is supported by other studies, indi-
cating that upper respiratory tract infections and gastro-
enteritis are the most common diagnoses after malaria 
among travellers returning from tropical countries [2, 25, 
27]. Whereas these infections usually have a benign and 
self-limiting clinical course, this may explain the finding 
that the majority of non-malaria cases were monitored 
in an outpatient setting and that the individuals did not 
attend scheduled return visits.
In addition to upper airway symptoms being more 
prevalent in the non-malaria cases, reports were detected 
of sore throat and nasal symptoms in 8.3–13.5 % of the 
malaria cases. A study conducted in the Brazilian Ama-
zon Region described the presence of nasal discharge, 
sneezing and sore throat in 18.1–22.2  % of patients 
diagnosed with malaria [22]. The hypothesis that con-
comitant upper respiratory tract viral infections were 
responsible entirely or partly for these symptoms cannot 
be discounted. Thus, even though these complaints are 
suggestive of common cold or influenza, upper airway 
symptoms described are associated with malaria.
In the present study, splenomegaly was not predictive 
of malaria and was reported in only 11  % of the cases. 
This percentage is considerably lower than that reported 
in other studies, which describe the presence of spleno-
megaly in 23–33 % of cases among travellers [19, 28, 29]. 
This difference may be due to the retrospective nature of 
this study. A high under-reporting of signs and symptoms 
was observed. The lack of detection during the physical 
examination due to negligence or inexperience of the 
attendant physician should also be considered. A care-
ful physical examination is important since splenomegaly 
has been shown to be the most important clinical predic-
tor of malaria [30].
With regard to laboratory tests, elevated biliru-
bin levels and thrombocytopaenia were the most 
prominent results related to the diagnosis of malaria. 
Although reductions in haemoglobin, haematocrit and 
white blood cell count were also more prevalent in the 
malaria cases, these abnormalities were not as pro-
nounced as the reduced platelet count. These results 
are in agreement with the results from other studies, 
which highlight hyperbilirubinaemia (total bilirubin 
>1.2  mg/dL) and thrombocytopaenia (platelet count 
<150  ×  103/μL) as the main laboratory predictors of 
malaria [25, 29, 30]. The use of the platelet count as a 
predictor of malaria can be particularly problematic in 
travellers returning from regions where dengue fever 
is also endemic, such as Brazil. Both are characterized 
by fever of acute onset and may present with similar 
abnormalities in the blood count tests, such as throm-
bocytopenia and leukopaenia, as well as elevations in 
aminotransferase levels. The presence of a rash, unu-
sual in malaria, normal levels of C-reactive protein and 
leukopaenia has been described more related to dengue 
fever than to malaria [31, 32]. In the present study it 
was also detected that dengue fever is more probable in 
subjects with normal total bilirubin levels and without 
reduced hemoglobin levels.
The present study has significant limitations, some 
having been mentioned previously. It should be noted 
that a clear selection bias is defined, considering that 
symptomatic patients were predominantly referred to 
the study centre. Due to the retrospective nature of the 
study, precise data on some variables included were not 
accurately registered, generating a considerable amount 
of missing data. Furthermore, the malaria diagnosis was 
defined exclusively through the use of the TST. The use 
of more sensitive methods, such as PCR, enables diagno-
ses in cases of infection with low parasitaemia, in which 
TST may provide a negative result. This method also 
better defines whether cases classified as severe vivax 
malaria are in fact cases of concomitant infection with P. 
falciparum.
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Conclusions
The results of this study provided relevant information 
regarding the management of suspected cases of malaria, 
in a real life scenario, in a centre outside an endemic area. 
The results indicate that in non-endemic regions a large 
number of patients experience a delay in seeking or being 
referring to medical attention. This suggests that outside 
endemic areas physicians are less familiar with the diag-
nostic aspects of malaria. Continuing medical education 
on the diagnosis of malaria is necessary in these regions. 
The results also indicate that the reporting of fever 
combined with a recent visit to an endemic area should 
promptly evoke the hypothesis of malaria. In these cases, 
specific diagnostic tests for malaria should be a priority. 
For cases that ‘jump’ this step, the presence of elevated 
bilirubin or thrombocytopaenia should also indicate a 
diagnosis of malaria.
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